Form 8-K - Current report:
SEC Accession No. 0001193125-13-192792
Filing Date
2013-05-01
Accepted
2013-05-01 17:07:35
Documents
3
Period of Report
2013-04-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d529009d8k.htm 8-K 16917
2 EX-99.1 d529009dex991.htm EX-99.1 11923
3 GRAPHIC g529009g16f85.jpg GRAPHIC 4486
  Complete submission text file 0001193125-13-192792.txt   36305
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27436 | Film No.: 13804151
SIC: 2836 Biological Products, (No Diagnostic Substances)